Omnicell Inc (OMCL)
29.26
-0.46
(-1.55%)
USD |
NASDAQ |
Jun 10, 16:00
29.26
0.00 (0.00%)
After-Hours: 16:53
Omnicell Cash from Financing (Quarterly): 11.93M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.93M |
| December 31, 2023 | 13.13M |
| September 30, 2023 | 2.825M |
| June 30, 2023 | 3.603M |
| March 31, 2023 | 3.862M |
| December 31, 2022 | 3.562M |
| September 30, 2022 | 9.056M |
| June 30, 2022 | -1.452M |
| March 31, 2022 | -32.12M |
| December 31, 2021 | 6.666M |
| September 30, 2021 | 18.28M |
| June 30, 2021 | 6.814M |
| March 31, 2021 | 15.60M |
| December 31, 2020 | 20.40M |
| September 30, 2020 | 468.18M |
| June 30, 2020 | 1.458M |
| March 31, 2020 | -33.77M |
| December 31, 2019 | -30.52M |
| September 30, 2019 | 8.628M |
| June 30, 2019 | -1.405M |
| March 31, 2019 | -0.178M |
| December 31, 2018 | -10.68M |
| September 30, 2018 | -3.474M |
| June 30, 2018 | -5.186M |
| March 31, 2018 | 5.741M |
| Date | Value |
|---|---|
| December 31, 2017 | 32.19M |
| September 30, 2017 | 5.29M |
| June 30, 2017 | -17.22M |
| March 31, 2017 | -30.14M |
| December 31, 2016 | 30.10M |
| September 30, 2016 | 5.023M |
| June 30, 2016 | -0.199M |
| March 31, 2016 | 228.83M |
| December 31, 2015 | -3.858M |
| September 30, 2015 | -18.22M |
| June 30, 2015 | -21.05M |
| March 31, 2015 | 6.575M |
| December 31, 2014 | -3.744M |
| September 30, 2014 | -5.803M |
| June 30, 2014 | 1.848M |
| March 31, 2014 | 7.493M |
| December 31, 2013 | -19.47M |
| September 30, 2013 | 14.04M |
| June 30, 2013 | 4.148M |
| March 31, 2013 | 8.659M |
| December 31, 2012 | 3.018M |
| September 30, 2012 | -0.718M |
| June 30, 2012 | -6.348M |
| March 31, 2012 | 3.816M |
| December 31, 2011 | -1.44M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-33.77M
Minimum
Mar 2020
468.18M
Maximum
Sep 2020
24.74M
Average
5.264M
Median
Cash from Financing (Quarterly) Benchmarks
| American Shared Hospital Services | 2.282M |
| Novo Integrated Sciences Inc | 0.0032M |
| Astrana Health Inc | 106.35M |
| Cryo-Cell International Inc | 0.539M |
| P3 Health Partners Inc | 11.40M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 49.95M |
| Cash from Investing (Quarterly) | -12.34M |
| Free Cash Flow | 164.56M |
| Free Cash Flow Per Share (Quarterly) | 0.8225 |
| Free Cash Flow to Equity (Quarterly) | 36.84M |
| Free Cash Flow to Firm (Quarterly) | 37.61M |
| Free Cash Flow Yield | 12.34% |